Photothermal Responsive Microcarriers Encapsulated With Cangrelor and 5‐Fu for Colorectal Cancer Treatment
Small Methods · 2024
DOI: 10.1002/smtd.202301002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2024. Verfasst von Wei Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Center, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, Chi…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Fluorouracil, Adenosine Monophosphate. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Nanjing Medical Science and Technique Development Foundation, Clinical Trials from Nanjing Drum Tower Hospital.
Abstract (Originalsprache)
Localized chemotherapy is emerging as a potential strategy for cancer treatment due to its low systemic toxicity. However, the immune evasion of tumor cells and the lack of an intelligent design of the delivery system limit its clinical application. Herein, photothermal responsive microcarriers are designed by microfluidic electrospray for colorectal tumor treatment. The microcarriers loaded with Cangrelor, 5‐FU and MXene (G‐M@F/C+NIR) show sustained delivery of antiplatelet drug Cangrelor, thus inhibiting the activity of platelets, interactions of platelet‐tumor cell, as well as the tumor cells invasion and epithelial‐mesenchymal transition (EMT). In addition, the sustained delivery of chemotherapeutics 5‐FU and the photothermal effect provided by MXene enable the microcarriers to inhibit tumor cells proliferation and migration. In vivo studies validate that the G‐M@F/C+NIR microcarriers significantly inhibites tumor growth, decreased the expression of Ki‐67 in tumor cells and vascular endothelial growth factor (VEGF) in the tumor microenvironment, while increased the expression of E‐cadherin. It is believe that by means of the proposed photothermal responsive microcarriers, the synergistic strategy of platelet inhibition, chemotherapy, and photothermal therapy can find practical applications in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory Center, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
- Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China.
- Zhongshan-Xuhui Hospital and the Shanghai Key Laboratory of Medical Epigenetics the International Co-laboratory of Medical Epigenetics and Metabolism Ministry of Science and Technology, Institutes of Biomedical Sciences…
ORCID-Profile: Wei Yang, Yuanjin Zhao
Förderung
- National Key Research and Development Program of China
- Nanjing Medical Science and Technique Development Foundation
- Clinical Trials from Nanjing Drum Tower Hospital
- Shenzhen Fundamental Research Program
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Yang, W., Wang, L., Fan, L., Li, W., Zhao, Y., Shang, L., & Jiang, M. (2024). Photothermal Responsive Microcarriers Encapsulated With Cangrelor and 5‐Fu for Colorectal Cancer Treatment. Small Methods. https://doi.org/10.1002/smtd.202301002
Vancouver
Yang W, Wang L, Fan L, Li W, Zhao Y, Shang L, et al. Photothermal Responsive Microcarriers Encapsulated With Cangrelor and 5‐Fu for Colorectal Cancer Treatment. Small Methods. 2024. doi:10.1002/smtd.202301002
BibTeX
@article{Yang2024,
author = {Yang, Wei and Wang, Li and Fan, Lu and Li, Wenzhao and Zhao, Yuanjin and Shang, Luoran and Jiang, Minghua},
title = {Photothermal Responsive Microcarriers Encapsulated With Cangrelor and 5‐Fu for Colorectal Cancer Treatment},
journal = {Small Methods},
year = {2024},
doi = {10.1002/smtd.202301002}
}
EUVIMED